Focused Ultrasound-Enhanced Nanoparticle Delivery in a Mouse Model for Tumor Therapy
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:28 min • August 7th, 2025
Loading...
Overview
This study demonstrates a method for disrupting the blood-brain barrier (BBB) using focused ultrasound in tumor-bearing mice. By employing fluorescently labeled nanoparticles, the research tracks their localization in the tumor region, providing insights into neurotherapeutic drug delivery.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Drug Delivery Systems
Background
- The blood-brain barrier protects the brain from harmful substances.
- Disruption of the BBB can enhance drug delivery to brain tumors.
- Focused ultrasound is a non-invasive technique for BBB disruption.
- Fluorescent nanoparticles can be used to visualize drug localization.
Purpose of Study
- To investigate the efficacy of focused ultrasound in disrupting the BBB.
- To assess the delivery of nanoparticles to brain tumors.
- To provide a method for tracking nanoparticle distribution in vivo.
Methods Used
- Utilization of anesthetized tumor-bearing mice.
- Integration of MRI scanning with focused ultrasound systems.
- Injection of contrast agents and fluorescently labeled nanoparticles.
- Application of focused ultrasound waves to induce BBB disruption.
Main Results
- Focused ultrasound successfully created temporary openings in the BBB.
- Fluorescent imaging confirmed the localization of nanoparticles in the tumor.
- Nanoparticles accumulated in the tumor and surrounding tissue.
- The method provides a potential strategy for enhancing drug delivery.
Conclusions
- Focused ultrasound is effective for BBB disruption in tumor models.
- Fluorescent nanoparticles can be tracked for drug delivery studies.
- This approach may improve therapeutic outcomes for brain tumors.
Frequently Asked Questions
What is the blood-brain barrier?
The blood-brain barrier is a selective permeability barrier that protects the brain from harmful substances while allowing essential nutrients to pass through.
How does focused ultrasound disrupt the BBB?
Focused ultrasound creates mechanical vibrations that cause microbubbles to expand and contract, leading to temporary openings in the tight junctions of the BBB.
What role do nanoparticles play in this study?
Nanoparticles are used to visualize and track drug delivery to the tumor after the BBB has been disrupted.
Is this method safe for use in humans?
While this study is conducted in mice, further research is needed to assess the safety and efficacy of this method in humans.
What are the potential applications of this research?
This research could lead to improved drug delivery methods for treating brain tumors and other neurological conditions.
Executive Industry Relevance
This method enables non-invasive, localized blood-brain barrier disruption to enhance nanoparticle-based drug delivery in brain tumor models. It provides a mechanistic de-risking strategy for neuro-oncology programs by improving target engagement predictability. The approach supports early discovery validation of BBB-penetrant therapeutics through quantitative imaging readouts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by enabling controlled BBB opening for nanoparticle delivery to tumor sites.
- Operational Value: Uses fluorescent nanoparticle tracking to validate target engagement and distribution in vivo.
- Predictive Value: Supports go/no-go decisions by confirming localized drug accumulation in tumor and peri-tumor regions.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems with quantified nanoparticle accumulation for downstream compound screening.
- Reproducibility: Enables standardized BBB disruption via MRI-guided focused ultrasound for consistent experimental conditions.
- Quantitative Output: Provides fluorescence-based readouts to measure nanoparticle localization and support assay optimization.
Translational & Preclinical Research
- Disease Relevance: Models brain tumor microenvironment to assess nanoparticle delivery in a pathophysiologically relevant context.
- Translational Continuity: Bridges discovery and preclinical stages by validating delivery mechanisms prior to therapeutic efficacy testing.
- Risk-Adjusted Advancement: Informs preclinical go/no-go decisions based on confirmed target site accumulation.
Pipeline & Workflow Integration
This technique integrates into the discovery workflow from target validation through lead identification, enabling mechanistic de-risking of CNS drug candidates.
- Discovery Biology: Supports hypothesis testing by validating whether therapeutic agents can reach intracranial targets following BBB modulation.
- Screening: Enhances assay readiness by providing reproducible, quantifiable nanoparticle delivery to brain tumors.
- Analytics: Generates fluorescence imaging data to compare delivery efficiency across conditions and guide lead optimization.
- Translational Research: Connects to preclinical validation by confirming target engagement in disease-relevant models.
- Enterprise Reuse: Establishes a reusable platform for evaluating BBB-penetrant modalities across multiple neuro-oncology projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in CNS drug delivery by demonstrating direct tumor accumulation post-BBB disruption.
- Operational Value: Delivers standardized, MRI-guided procedure with quantifiable fluorescence outputs for cross-site reproducibility.
- Strategic Value: Reduces biological risk in CNS programs by enabling early validation of target site exposure.
- Portfolio Impact: Facilitates risk-adjusted resource allocation by identifying candidates with confirmed brain tumor delivery.
Implementation Considerations
- Requires expertise in preclinical imaging, focused ultrasound operation, and nanoparticle handling.
- Depends on integrated MRI-focused ultrasound systems and fluorescence imaging infrastructure.
- Necessitates standardization across teams for consistent ultrasound parameters and nanoparticle dosing.
- Involves adaptation considerations when translating from murine models to larger preclinical systems.
- Limited by the transient nature of BBB opening, requiring precise temporal coordination of drug administration.
Biopharma FAQs
Why does nanoparticle accumulation matter for target validation?
Nanoparticle accumulation confirms successful delivery to the tumor site following blood-brain barrier disruption, providing direct evidence of target engagement. This measurement supports go/no-go decisions by validating whether therapeutic agents can reach intracranial targets in vivo.
How does focused ultrasound enable independent variable isolation in BBB studies?
Focused ultrasound allows precise, localized disruption of the blood-brain barrier at the tumor site while leaving surrounding vasculature intact. This isolation enables researchers to attribute nanoparticle delivery specifically to BBB opening rather than systemic effects.
What quantitative measurements does fluorescence imaging enable for nanoparticle delivery?
Fluorescence imaging provides quantitative readouts of nanoparticle localization and accumulation within the tumor and surrounding tissue. These measurements allow comparison of delivery efficiency across experimental conditions and support assay standardization.
Why are replication requirements important for focused ultrasound BBB disruption?
Replication ensures consistent and reproducible blood-brain barrier opening across experiments, which is critical for reliable nanoparticle delivery data. Standardized replication supports cross-functional collaboration by providing dependable results for target validation and lead selection.
What statistical analysis is needed before implementing focused ultrasound for nanoparticle delivery studies?
Statistical analysis is required to confirm significant differences in nanoparticle accumulation between treated and control groups, validating the efficacy of blood-brain barrier disruption. This analysis supports confident interpretation of delivery data and informs go/no-go decisions in preclinical programs.
08:58
A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model
Related Videos
0 Views
07:34
Delivery of Antibodies into the Brain Using Focused Scanning Ultrasound
Related Videos
0 Views
03:32
Monitoring Blood-Brain Barrier Opening in Rats with a Preclinical Focused Ultrasound System
Related Videos
0 Views
14:10
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Related Videos
0 Views
08:04
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
Related Videos
0 Views
03:10
Treatment of Brain Tumors in a Mouse Model Using Sonodynamic Therapy
Related Videos
0 Views
02:29
Intravenous Administration of Therapeutic Nanoparticles in a Murine Glioblastoma Model
Related Videos
0 Views
08:19
Controllable Nucleation of Cavitation from Plasmonic Gold Nanoparticles for Enhancing High Intensity Focused Ultrasound Applications
Related Videos
0 Views
09:01
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Related Videos
0 Views
06:45
In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
Related Videos
0 Views
Last updated: 1 August 2026